Technical Analysis for SWTX - SpringWorks Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 37.44 | -1.29% | -0.49 |
SWTX closed down 1.29 percent on Wednesday, November 20, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| 180 Bullish Setup | Bullish Swing Setup | -1.29% | |
| Upper Bollinger Band Walk | Strength | -1.29% | |
| Outside Day | Range Expansion | -1.29% |
| Alert | Time |
|---|---|
| Down 3% | about 19 hours ago |
| 60 Minute Opening Range Breakdown | about 20 hours ago |
| Possible NR7 | about 20 hours ago |
| Down 2 % | about 23 hours ago |
| Down 1% | about 24 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Springworks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Rare Diseases Drug Development
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Rare Diseases Drug Development
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 53.92 |
| 52 Week Low | 20.1919 |
| Average Volume | 1,146,740 |
| 200-Day Moving Average | 40.00 |
| 50-Day Moving Average | 32.57 |
| 20-Day Moving Average | 32.83 |
| 10-Day Moving Average | 35.13 |
| Average True Range | 2.02 |
| RSI (14) | 66.56 |
| ADX | 17.96 |
| +DI | 25.97 |
| -DI | 16.25 |
| Chandelier Exit (Long, 3 ATRs) | 32.53 |
| Chandelier Exit (Short, 3 ATRs) | 34.26 |
| Upper Bollinger Bands | 38.26 |
| Lower Bollinger Band | 27.39 |
| Percent B (%b) | 0.92 |
| BandWidth | 33.11 |
| MACD Line | 1.34 |
| MACD Signal Line | 0.67 |
| MACD Histogram | 0.669 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 40.19 | ||||
| Resistance 3 (R3) | 40.27 | 39.42 | 39.73 | ||
| Resistance 2 (R2) | 39.42 | 38.72 | 39.39 | 39.58 | |
| Resistance 1 (R1) | 38.43 | 38.29 | 38.01 | 38.36 | 39.43 |
| Pivot Point | 37.59 | 37.59 | 37.38 | 37.55 | 37.59 |
| Support 1 (S1) | 36.60 | 36.89 | 36.18 | 36.52 | 35.45 |
| Support 2 (S2) | 35.75 | 36.45 | 35.72 | 35.30 | |
| Support 3 (S3) | 34.76 | 35.75 | 35.15 | ||
| Support 4 (S4) | 34.69 |
